Skip to content

Trial Summary

The objective of this study is to assess safety and efficacy of BA3071 in solid tumors



ACTRN/NCT /ethics:


Scientific title:

A Phase 1/2 Study of BA3071

Sponsor / Cooperative group:

BioAtla, Inc.

Trial & Patient Characteristics

Cancer TypeSolid cancers
Trial TypeTreatment
PhasePhase I; Phase II
Age Range18 years and older
Tumour Stream -
Cancer StageLocally Advanced
Anticipated Start Date2022-08-03
Anticipated End Date2024-06-30

Participating Hospitals

HospitalCancer Research SA
Clinical Trial CoordinatorKelly Mead/Kate Penda
Phone08 8359 2565
Principal InvestigatorDr Vineet Kwatra
Recruitment StatusRecruiting